These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 24697296)
61. Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats. Zini S; Masdehors P; Lenkei Z; Fournie-Zaluski MC; Roques BP; Corvol P; Llorens-Cortes C Neuroscience; 1997 Jun; 78(4):1187-93. PubMed ID: 9174084 [TBL] [Abstract][Full Text] [Related]
62. Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats. Yang K; Wang Y; Ding Y; Cui H; Zhou D; Chen L; Ma Z; Wang W; Zhang W; Luan J Chronobiol Int; 2019 Aug; 36(8):1058-1071. PubMed ID: 31096810 [No Abstract] [Full Text] [Related]
63. Influence of dietary sodium on the blood pressure and renal sympathetic nerve activity responses to intracerebroventricular angiotensin II and angiotensin III in anaesthetized rats. Houghton BL; Huang C; Johns EJ Exp Physiol; 2010 Feb; 95(2):282-95. PubMed ID: 19880539 [TBL] [Abstract][Full Text] [Related]
64. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats. Dai SY; Peng W; Zhang YP; Li JD; Shen Y; Sun XF J Neuroinflammation; 2015 Mar; 12():47. PubMed ID: 25885968 [TBL] [Abstract][Full Text] [Related]
65. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
66. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension. French JF; Anderson BA; Downs TR; Dage RC J Cardiovasc Pharmacol; 1995 Jul; 26(1):107-13. PubMed ID: 7564349 [TBL] [Abstract][Full Text] [Related]
67. Mammary renin-angiotensin system-regulating aminopeptidase activities are modified in rats with breast cancer. del Pilar Carrera M; Ramírez-Expósito MJ; Mayas MD; García MJ; Martínez-Martos JM Tumour Biol; 2010 Dec; 31(6):583-8. PubMed ID: 20652663 [TBL] [Abstract][Full Text] [Related]
68. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system. Gammelgaard I; Wamberg S; Bie P Acta Physiol (Oxf); 2006 Oct; 188(2):129-38. PubMed ID: 16948800 [TBL] [Abstract][Full Text] [Related]
69. The effect of recombinant aminopeptidase A on hypertension in spontaneously hypertensive rats: its effect in comparison with candesartan. Ishii M; Hattori A; Numaguchi Y; Tsujimoto M; Ishiura S; Kobayashi H; Murohara T; Wright JW; Mizutani S Horm Metab Res; 2008 Dec; 40(12):887-91. PubMed ID: 18726831 [TBL] [Abstract][Full Text] [Related]
70. The C-terminal domain of aminopeptidase A is an intramolecular chaperone required for the correct folding, cell surface expression, and activity of this monozinc aminopeptidase. Rozenfeld R; Muller L; El Messari S; Llorens-Cortes C J Biol Chem; 2004 Oct; 279(41):43285-95. PubMed ID: 15263000 [TBL] [Abstract][Full Text] [Related]
71. Kidney aminopeptidase A and hypertension, part I: spontaneously hypertensive rats. Healy DP; Song L Hypertension; 1999 Feb; 33(2):740-5. PubMed ID: 10024338 [TBL] [Abstract][Full Text] [Related]
72. Role of the brain renin-angiotensin system in the maintenance of blood pressure in conscious spontaneously hypertensive and sinoaortic baroreceptor-denervated rats. Paull JR; Bunting MW; Widdop RE Clin Exp Pharmacol Physiol; 1997; 24(9-10):667-72. PubMed ID: 9315367 [TBL] [Abstract][Full Text] [Related]
73. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863 [TBL] [Abstract][Full Text] [Related]
74. Contribution of molecular modeling and site-directed mutagenesis to the identification of a new residue, glutamate 215, involved in the exopeptidase specificity of aminopeptidase A. Rozenfeld R; Iturrioz X; Okada M; Maigret B; Llorens-Cortes C Biochemistry; 2003 Dec; 42(50):14785-93. PubMed ID: 14674752 [TBL] [Abstract][Full Text] [Related]
75. Possible involvement of aminopeptidase A in hypertension in spontaneously hypertensive rats (SHRs) and change of refractoriness in response to angiotensin II in pregnant SHRs. Nakashima Y; Ohno Y; Itakura A; Takeuchi M; Murata Y; Kuno N; Mizutani S J Hypertens; 2002 Nov; 20(11):2233-8. PubMed ID: 12409962 [TBL] [Abstract][Full Text] [Related]
76. Possible involvement of aminopeptidase A in hypertension and renal damage in Dahl salt-sensitive rats. Nomura M; Nomura S; Mitsui T; Suzuki M; Kobayashi H; Ito T; Itakura A; Kikkawa F; Mizutani S Am J Hypertens; 2005 Apr; 18(4 Pt 1):538-43. PubMed ID: 15831365 [TBL] [Abstract][Full Text] [Related]
77. New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertension. Monge M; Lorthioir A; Bobrie G; Azizi M J Renin Angiotensin Aldosterone Syst; 2013 Dec; 14(4):285-9. PubMed ID: 24222656 [TBL] [Abstract][Full Text] [Related]
78. Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology. Kehoe PG; Hibbs E; Palmer LE; Miners JS J Alzheimers Dis; 2017; 58(1):203-214. PubMed ID: 28387670 [TBL] [Abstract][Full Text] [Related]
79. Kidney aminopeptidase A and hypertension, part II: effects of angiotensin II. Song L; Healy DP Hypertension; 1999 Feb; 33(2):746-52. PubMed ID: 10024339 [TBL] [Abstract][Full Text] [Related]